Skip to main content
. 2019 Jul 12;6(9):ofz328. doi: 10.1093/ofid/ofz328

Table 3.

Participant Characteristics by Pre-antiretroviral Therapy Initiation Community State Type Assignment

CST-1 CST-2 CST-3 CST-4 CST-5
26 (28.3) 28 (30.4) 24 (26.1) 3 (3.3) 11 (12.0) P
Baseline age, y .275
 20–29 5 (19.2) 7 (25.0) 8 (33.3) 1 (33.3) 2 (18.2)
 30–39 14 (53.8) 11 (39.3) 9 (37.5) 2 (66.7) 3 (27.3)
 40–49 6 (23.1) 8 (28.6) 7 (29.2) 0 (0.0) 1 (9.1)
 50+ 1 (3.8) 2 (7.1) 0 (0.0) 0 (0.0) 5 (45.5)
Baseline BMI, kg/m2 .645
 <18.5 3 (11.5) 3 (10.7) 0 (0.0) 0 (0.0) 2 (18.2)
 18.5–24.9 18 (69.2) 19 (67.9) 20 (83.3) 2 (66.7) 7 (63.6)
 25+ 5 (19.2) 6 (21.4) 4 (16.7) 1 (33.3) 2 (18.2)
Baseline CD4 count, cells/μL .098
 <200 8 (30.8) 13 (46.4) 10 (41.7) 0 (0.0) 8 (72.7)
 200–450 18 (69.2) 15 (53.6) 14 (58.3) 3 (100.0) 3 (27.3)
Baseline HIV viral load, copies/mL .486
 <10 000 2 (7.7) 6 (21.4) 3 (12.5) 1 (33.3) 1 (9.1)
 10 000–99 999 12 (46.2) 9 (32.1) 10 (41.7) 0 (0.0) 2 (18.2)
 100 000+ 12 (46.2) 13 (46.4) 11 (45.8) 2 (66.7) 8 (72.7)

Data are presented as No. (%). P values from the Fisher exact test.

Abbreviations: BMI, body mass index; CST, community state type.